A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

Inclusion Criteria: * Have a clinical diagnosis of uncontrolled Type 2 Diabetes based on the World Health Organization classification or other locally applicable diagnostic standards, and who intend to fast during Ramadan * Have HbA1c ≥7% within 30 days prior to screening * Are glucagon-like peptide-1 receptor agonist (GLP-1 RA) naïve * Have had stable body weight self-reported change ≤5 kilograms (kg) during the 90 days prior to screening * Have body mass index ≥25 kilograms per square meter (kg/m2) at screening Exclusion Criteria: * Have Type 1 Diabetes or gestational diabetes * Have a history of chronic or acute pancreatitis * Have acute or chronic hepatitis * Have evidence of a significant, uncontrolled endocrine abnormality * Have a history of an active or untreated malignancy * Have New York Heart Association Functional Classification IV congestive heart failure * Have been treated with insulin within two weeks prior to screening